The U.S. is increasing production of ZMapp, but it might not be enough

The U.S. is increasing production of ZMapp, but it might not be enough
(Image credit: Sean Gallup/Getty Images)

The Department of Health and Human Services is increasing its production of ZMapp, the leading experimental drug that's been used to treat those infected with Ebola in West Africa.

The New York Times reports that federal officials are in talks with Caliber Biotherapeutics, a Texas-based drug manufacturer, to produce ZMapp. An anonymous federal official told the Times that the government is considering several manufacturers, including Caliber. But ZMapp supplies may be limited to hundreds of thousands of treatment courses, which may not be enough if the current Ebola outbreak "continues to spiral out of control," according to the Times.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Meghan DeMaria

Meghan DeMaria is a staff writer at TheWeek.com. She has previously worked for USA Today and Marie Claire.